Back
Range Cancer Therapeutics ETF 10K Form
Sell
44
CNCR
Range Cancer Therapeutics ETF
Last Price:
13.62
Seasonality Move:
2.72%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive CNCR News And Ratings
See the #1 stock for the next 7 days that we like better than CNCR
CNCR Financial Statistics
Sales & Book Value
| Annual Sales: | -- |
|---|---|
| Cash Flow: | $0 |
| Price / Cash Flow: | 0 |
| Annual Sales: | $0.00 |
| Price / Book: | 0 |
Profitability
| Net Income (TTM): | $0 |
|---|---|
| Gross Margin: | -- |
| Return on Equity: | 0% |
| Return on Assets: | 0% |
Range Cancer Therapeutics ETF Earnings Forecast
Key Range Cancer Therapeutics ETF Financial Ratios
Range Cancer Therapeutics ETF Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Current Symbol: | CNCR |
| CUSIP: | 26922A |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 0 |
| Quick Ratio: | 0 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
CNCR Technical Analysis vs Fundamental Analysis
Sell
44
Range Cancer Therapeutics ETF (CNCR)
is a Sell
Is Range Cancer Therapeutics ETF a Buy or a Sell?
-
Range Cancer Therapeutics ETF stock is rated a Sell
The current Range Cancer Therapeutics ETF [CNCR] share price is $13.22. The Score for CNCR is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.